Seller record · Telehealth service
Walgreens Weight Management
Fails 2 of 8 criteria. S3, pharmacy identification: The program page does not name the pharmacy that fills a weight management prescription. It names the chain's own pharmacy only for a separate Medicare program, and the virtual care page says only that a prescription can be filled in store or delivered. 1 more criterion also fails; see the table below.
At a glance
Walgreens Weight ManagementTelehealth service
- Price
- Visits $49; Wegovy pill and Foundayo from $149 a month with a manufacturer offer
- Sells
- Wegovy pill, Wegovy injection, Zepbound KwikPen and vials, and 3 more
- FDA letters
- 1 on file
Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.
The weight management program of a national pharmacy chain's virtual care service, in which a doctor or nurse practitioner from its affiliated medical practices meets the patient by video and may prescribe a brand GLP-1 drug: Wegovy, Zepbound, Foundayo or Saxenda. Visits are paid one at a time with no subscription, and the medication is priced separately through the manufacturers' self-pay offers.
Operating entity Walgreen Co.
Dispositions
| Code | Criterion | Disposition | Where it appears |
|---|---|---|---|
| S1 | Prescriber requirement | PASS | Walgreens Weight Management's weight loss page; Walgreens Weight Management's terms of use page |
| S2 | Prescription gating | PASS | Walgreens Weight Management's weight loss page; Walgreens Weight Management's virtual healthcare page |
| S3 | Pharmacy identification | FAIL | Walgreens Weight Management's weight loss page; Walgreens Weight Management's virtual healthcare page |
| S4 | Compounding disclosure | PASS | Walgreens Weight Management's weight loss page |
| S5 | Analytical documentation | FAIL | Walgreens Weight Management's weight loss page |
| S6 | Business address | PASS | Walgreens Weight Management's terms of use page |
| S7 | Price disclosure | PASS | Walgreens Weight Management's weight loss page |
| S8 | Enforcement status | PASS | FDA warning-letter index |
Evidence, criterion by criterion
The evidence behind each disposition in the table above, where it appears, and its date.
Products shown on the seller's own pages at the recorded date: Wegovy pill, Wegovy injection, Zepbound KwikPen and vials, Foundayo, Saxenda, weight management video visit.
Other sellers of the same products
Who sells semaglutideWho sells tirzepatideWho sells liraglutide
Enforcement documents on file: 1 warning letter
FDA warning letter 663404, issued September 2023, to Walgreens Boots Alliance, Inc.Homeopathic eye drops sold under the Walgreens name on Walgreens Weight Management's website are unapproved new drugs, and are adulterated because a contract manufacturer made them outside current good manufacturing practice.
A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.